(Total Views: 326)
Posted On: 10/31/2019 11:03:18 AM
Post# of 36568
AE37 currently has nothing to do w the success Keytruda is having. It is in Phase II trial to prove that a Keytruda/AE37 combo is better than Keytruda alone. Hopefully MRK sees enough potential for it to throw some $ at the NGIO spin while they wait for the results...
==========
This is what I don't understand as well. If AE37 is working alongside and helps, isn't it part of the success that Keytruda is having or is it just in a trial phase of another aspect of Keytruda they are doing and has no bearing on the overall Keytruda of Merck?
==========
This is what I don't understand as well. If AE37 is working alongside and helps, isn't it part of the success that Keytruda is having or is it just in a trial phase of another aspect of Keytruda they are doing and has no bearing on the overall Keytruda of Merck?
(0)
(0)
